The decisions made at the NENC Medicines Subcommittee February 2024 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/
This includes the recommendations made by NTAG at its January 2024 meeting and NICE Technology appraisals from the 1st October 2023 to 30th November 2023.
The following guidelines/position statements were approved and can be found at:
- NENC Shared Care Protocol Amiodarone for patients in adult services version 2 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol Dronedarone for patients in adult services version 2 https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol Riluzole for patients in adult service https://ntag.nhs.uk/shared-care-guidelines/
- Finerenone for treating chronic kidney disease in people with type 2 diabetes https://ntag.nhs.uk/guidelines/
- NENC Penicillin Allergy Assessment primary care for adult patients – approved Feb 2024 https://ntag.nhs.uk/guidelines/
- NENC Position statement on the prescribing of branded generic medication https://ntag.nhs.uk/guidelines/
- NENC shared care guideline template https://ntag.nhs.uk/wp-content/uploads/2024/02/NENC-share-care-template-approved-Feb-2024.docx